Jiro Kato

Title: Jiro Kato: Innovator in ADP-Ribosylation Research

Introduction

Jiro Kato is a prominent inventor based in Rockville, MD (US). He has made significant contributions to the field of biochemistry, particularly in the area of ADP-ribosylation. His work focuses on the mechanisms and applications of ADP-ribosyl acceptor hydrolase 3 (ARH3) polypeptides.

Latest Patents

Jiro Kato holds a patent for "ADP-ribosyl acceptor hydrolase 3 (ARH3) polypeptides and methods of use." This patent provides methods for catalyzing the release of ADP-ribose from poly(ADP-ribose) or O-acetyl-ADP-ribose. It also outlines methods for modifying DNA repair or chromatin structure by introducing agents that modify the activity of an ARH3 polypeptide, or its variants or fragments. Furthermore, the patent includes methods for screening molecules involved in the poly(ADP-ribosyl)ation of proteins or O-acetyl-ADP-ribose content, as well as methods for treating disorders by altering the activity of an ARH3 protein. Jiro Kato has 1 patent to his name.

Career Highlights

Jiro Kato is affiliated with the United States of America, as Represented by the Secretary, Department of Health and Human Services. His work has been instrumental in advancing the understanding of ADP-ribosylation and its implications in various biological processes.

Collaborations

Jiro Kato has collaborated with notable colleagues, including Joel Moss and Shunya Oka. Their combined expertise has contributed to the success of their research endeavors.

Conclusion

Jiro Kato's innovative work in the field of ADP-ribosylation has paved the way for new therapeutic approaches and a deeper understanding of cellular mechanisms. His contributions continue to impact the scientific community positively.